These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6393859)

  • 1. The effect of prostaglandin modulators on prostate tumor growth and metastasis.
    Drago JR; Al-Mondhiry HA
    Anticancer Res; 1984; 4(6):391-4. PubMed ID: 6393859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575).
    Honn KV; Meyer J; Neagos G; Henderson T; Westley C; Ratanatharathorn V
    Prog Clin Biol Res; 1982; 89():295-331. PubMed ID: 7051034
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug treatments for metastasis of the Lewis lung carcinoma: lack of correlation between inhibition of lung metastasis and survival.
    Merriman RL; Shackelford KA; Tanzer LR; Campbell JB; Bemis KG; Matsumoto K
    Cancer Res; 1989 Aug; 49(16):4509-16. PubMed ID: 2743339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent, nafazatrom.
    Marnett LJ; Siedlik PH; Ochs RC; Pagels WR; Das M; Honn KV; Warnock RH; Tainer BE; Eling TE
    Mol Pharmacol; 1984 Sep; 26(2):328-35. PubMed ID: 6434940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.
    Ambrus JL; Ambrus CM; Gastpar H; Williams P
    J Med; 1982; 13(1-2):35-47. PubMed ID: 6288824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of heparin in control of metastasis of Nb rat androgen-insensitive prostate carcinoma.
    Drago JR; Weed P; Fralisch A
    Anticancer Res; 1984; 4(3):171-2. PubMed ID: 6540544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system.
    Getzenberg RH; Light BW; Lapco PE; Konety BR; Nangia AK; Acierno JS; Dhir R; Shurin Z; Day RS; Trump DL; Johnson CS
    Urology; 1997 Dec; 50(6):999-1006. PubMed ID: 9426741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL; Schwartz GG; Selzer MG; Burnstein KL; Zhuang SH; Block NL; Binderup L
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):241-8. PubMed ID: 10090302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selective estrogen receptor modulator trioxifene (LY133314) inhibits metastasis and extends survival in the PAIII rat prostatic carcinoma model.
    Neubauer BL; McNulty AM; Chedid M; Chen K; Goode RL; Johnson MA; Jones CD; Krishnan V; Lynch R; Osborne HE; Graff JR
    Cancer Res; 2003 Sep; 63(18):6056-62. PubMed ID: 14522935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of mice with NC carcinoma is unchanged by drugs that are thought to inhibit thromboxane synthesis or increase prostacyclin formation.
    Stamford IF; Melhuish PB; Carroll MA; Corrigan CJ; Patel S; Bennett A
    Br J Cancer; 1986 Aug; 54(2):257-63. PubMed ID: 3755610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a beta-adrenergic antagonist and a prostaglandin synthesis inhibitor.
    Melamed R; Rosenne E; Shakhar K; Schwartz Y; Abudarham N; Ben-Eliyahu S
    Brain Behav Immun; 2005 Mar; 19(2):114-26. PubMed ID: 15664784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse.
    Wechter WJ; Leipold DD; Murray ED; Quiggle D; McCracken JD; Barrios RS; Greenberg NM
    Cancer Res; 2000 Apr; 60(8):2203-8. PubMed ID: 10786685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eicosanoids and metastasis: experimental aspects in Lewis lung carcinoma.
    Karmali RA; Choi K; Otter G; Schmid F
    Cancer Biochem Biophys; 1986 Dec; 9(1):97-104. PubMed ID: 3815323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nafazatrom (Bay g-6575), an antithrombotic and antimetastatic agent, inhibits 15-hydroxyprostaglandin dehydrogenase.
    Wong PY; Chao PH; McGiff JC
    J Pharmacol Exp Ther; 1982 Dec; 223(3):757-60. PubMed ID: 6754908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model.
    Narayanan BA; Narayanan NK; Pittman B; Reddy BS
    Clin Cancer Res; 2004 Nov; 10(22):7727-37. PubMed ID: 15570007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of a polyherbal preparation, Brahma rasayana against tumor growth and lung metastasis in rat prostate model system.
    Gaddipati JP; Rajeshkumar NV; Thangapazham RL; Sharma A; Warren J; Mog SR; Singh AK; Maheshwari RK
    J Exp Ther Oncol; 2004 Oct; 4(3):203-12. PubMed ID: 15724840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcina of the mouse prostate growth inhibition by celecoxib: downregulation of transcription factors involved in COX-2 inhibition.
    Narayanan BA; Narayanan NK; Pttman B; Reddy BS
    Prostate; 2006 Feb; 66(3):257-65. PubMed ID: 16175586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small intestinal submucosa does not promote PAIII tumor growth in Lobund-Wistar rats.
    Hodde JP; Suckow MA; Wolter WR; Hiles MC
    J Surg Res; 2004 Aug; 120(2):189-94. PubMed ID: 15234212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.